General Information of MET (ID: META00627) |
Name |
7-Alpha-Hydroxy-3-oxo-4-cholestenoate
|
Synonyms |
Click to Show/Hide Synonyms of This Metabolite
(7alpha)-7-Hydroxy-3-oxocholest-4-en-26-Oate; (7alpha)-7-Hydroxy-3-oxocholest-4-en-26-Oic acid; 7-Hoca; 7-alpha-Hydroxy-3-oxo-4-cholestenoate; 7a-Hydroxy-3-oxo-4-cholestenoate; 7a-Hydroxy-3-oxo-4-cholestenoic acid; 7alpha-Hydroxy-3-oxo-4-cholestenoate; 7alpha-Hydroxy-3-oxocholest-4-en-26-Oic acid
|
Source |
Aliphatic homopolycyclic compounds
|
Structure Type |
Bile acids, alcohols and derivatives (Click to Show/Hide the Complete Structure Type Hierarchy)
Lipids and lipid-like molecules
Steroids and steroid derivatives
Bile acids, alcohols and derivatives
|
PubChem CID |
|
HMDB ID |
|
Formula |
C27H42O4
|
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3081085"></iframe>
|
 |
3D MOL
|
2D MOL
|
|
Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
|
KEGG ID |
|
ChEBI ID |
|
ChemSpider ID |
|
Physicochemical Properties |
Molecular Weight |
430.6 |
Topological Polar Surface Area |
74.6 |
XlogP |
5.9 |
Complexity |
756 |
Heavy Atom Count |
31 |
Rotatable Bond Count |
6 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
4 |
Function |
7alpha-Hydroxy-3-oxo-4-cholestenoate, also known as 7-Hoca, is a member of the class of compounds known as monohydroxy bile acids, alcohols, and derivatives. Thes compounds are bile acids, alcohols, or any of their derivatives bearing a hydroxyl group. 7alpha-Hydroxy-3-oxo-4-cholestenoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 7alpha-Hydroxy-3-oxo-4-cholestenoate is involved in metabolic disorders such as 27-hydroxylase deficiency, familial hypercholanemia (FHCA), and Zellweger syndrome. 7alpha-Hydroxy-3-oxo-4-cholestenoate is involved in the primary bile acid biosynthesis pathway. 7alpha-Hydroxy-3-oxo-4-cholestenoate is created from either 3beta,7alpha-dihydroxy-5-cholestenoate or 7alpha,26-dihydroxy-4-cholesten-3-one through the actions of HSD3B7 (EC 1.1.1.181) or CYP27A (EC 1.14.13.15), respectively.
|
Regulatory Network
|
|
|
|
|
|
|
|